At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,223 enrolled
Drug / intervention
Defibrillator, Dual Chamber ; Implantable +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Diagnostic Data Influence on Disease Management and Relation of Genetic Polymorphisms to Tachy-arrhythmia in ICD Patients.
In Brief
A clinical study evaluating Defibrillator, Dual Chamber ; Implantable and Blood sampling for Death, Sudden, Cardiac and 4 related conditions. Completed, enrolled 1,223 participants.
Detailed Summary
To prospectively evaluate if the analysis of genetic polymorphisms can be used to identify patients at risk of ventricular tachycardia. To evaluate the influence of ICD-based diagnostic information on the long term treatment and management of primary prevention ICD-patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDeath, Sudden, Cardiac, Ventricular Fibrillation, Tachycardia, Atrial Fibrillation, Sick Sinus Syndrome
Countries--
Collaborators--
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2007
First PostedMay 2007
Primary CompletionJul 2012
Study CompletionDec 2012
TodayJul 2026
First PostedMay 25, 2007
Enrollment StartFeb 1, 2007
Primary CompletionJul 1, 2012
Study CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 5.4 yearsPosted 19.1 years ago
Interventions
Defibrillator, Dual Chamber ; Implantabledevice
Patient must wear a dual chamber ICD to remain in study. Can be enrolled 10 days prior to implant. Is excluded if device type changes.
Blood samplingprocedure
Blood sampling